Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
Conference Coverage
Simplify cardiac risk assessment for rheumatologic conditions
Publish date:
June 14, 2016
AT THE EULAR 2016 CONGRESS
References
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge
YouTube channel
.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge
YouTube channel
.
Pages
« first
1
2
3
Recommended Reading
The Rheumatoid Arthritis Support Network
MDedge Internal Medicine
Registry study adds evidence for use of DMARD combo first in early RA
MDedge Internal Medicine
Analysis provides key questions – and answers – regarding future of JAK inhibitors for RA
MDedge Internal Medicine
Early RA remission more unstable in the presence of foot synovitis
MDedge Internal Medicine
Inflectra becomes first FDA-approved biosimilar for inflammatory diseases
MDedge Internal Medicine
Remicade to infliximab biosimilar switches fare well in real-life practice
MDedge Internal Medicine
Make informed treatment decisions about biosimilars
MDedge Internal Medicine
Anti-TNF certolizumab pegol effective in early RA
MDedge Internal Medicine
Hydroxychloroquine, abatacept linked with reduced type 2 diabetes
MDedge Internal Medicine
VIDEO: Smoking, excess weight hinder sustained remission in early RA
MDedge Internal Medicine
Cardiology
Rheumatology
All Specialties